RANZCP homepage
Proposal to Fund Lisdexamfetamine for Attention Deficit Hyperactivity Disorder
Submission
Last updated: Sep 2024
Published in New Zealand
Reference: 13NZ
RANZCP NZ Submission to Pharmac regarding the Proposal to Fund Lisdexamfetamine for Attention Deficit Hyperactivity Disorder
Resources
